Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger W Chapman

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Molecular Cancer Therapeutics|July 28, 2019
Preclinical Development of U3-1784, a Novel FGFR4 Antibody Against Cancer, and Avoidance of Its On-target ToxicityRené Bartz, Keisuke Fukuchi, Toshiaki Ohtsuka, et al.
Hepatology (Baltimore, Md.)|December 20, 2018
Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring SystemElizabeth C Goode, Allan B Clark, George F Mells, et al.
Hepatology (Baltimore, Md.)|November 24, 2016
Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort studyElisabeth M G de Vries, Manon de Krijger, Martti Färkkilä, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 19, 2020
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing CholangitisCharlotte Rose Hawkey Hedin, Gina Sado, Nelson Ndegwa, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 18, 2019
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel DiseasesKate D Lynch, Roger W Chapman, Satish Keshav, et al.
Gastroenterology|March 10, 2017
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing CholangitisTobias J Weismüller, Palak J Trivedi, Annika Bergquist, et al.
Nature Genetics|December 20, 2016
Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel diseaseSun-Gou Ji, Brian D Juran, Sören Mucha, et al.
Gut|August 6, 2017
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitisRudi Alberts, Elisabeth M G de Vries, Elizabeth C Goode, et al.
Nature Genetics|April 23, 2013
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitisJimmy Z Liu, Johannes Roksund Hov, Trine Folseraas, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Molecular Cancer Therapeutics|July 28, 2019
Preclinical Development of U3-1784, a Novel FGFR4 Antibody Against Cancer, and Avoidance of Its On-target ToxicityRené Bartz, Keisuke Fukuchi, Toshiaki Ohtsuka, et al.
Hepatology (Baltimore, Md.)|December 20, 2018
Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring SystemElizabeth C Goode, Allan B Clark, George F Mells, et al.
Hepatology (Baltimore, Md.)|November 24, 2016
Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort studyElisabeth M G de Vries, Manon de Krijger, Martti Färkkilä, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 19, 2020
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing CholangitisCharlotte Rose Hawkey Hedin, Gina Sado, Nelson Ndegwa, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 18, 2019
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel DiseasesKate D Lynch, Roger W Chapman, Satish Keshav, et al.
Gastroenterology|March 10, 2017
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing CholangitisTobias J Weismüller, Palak J Trivedi, Annika Bergquist, et al.
Nature Genetics|December 20, 2016
Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel diseaseSun-Gou Ji, Brian D Juran, Sören Mucha, et al.
Gut|August 6, 2017
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitisRudi Alberts, Elisabeth M G de Vries, Elizabeth C Goode, et al.
Nature Genetics|April 23, 2013
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitisJimmy Z Liu, Johannes Roksund Hov, Trine Folseraas, et al.
Pageof 7